pimobendan has been researched along with Shock, Cardiogenic in 2 studies
pimobendan: produces arterial & venous dilatation in dogs; structure given in first source
Shock, Cardiogenic: Shock resulting from diminution of cardiac output in heart disease.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Koizumi, T | 1 |
| Taguchi, S | 1 |
| Lehot, JJ | 1 |
2 other studies available for pimobendan and Shock, Cardiogenic
| Article | Year |
|---|---|
Low-dose oral pimobendan emancipates patients with severe ischemic pump failure from intravenous catecholamine infusion for cardiogenic shock.
Topics: Administration, Oral; Aged, 80 and over; Cardiotonic Agents; Catecholamines; Dose-Response Relations | 2016 |
[New positive inotropic drugs].
Topics: Adrenergic Agonists; Amrinone; Cardiotonic Agents; Dopamine; Enoximone; Hemodynamics; Humans; Imidaz | 1991 |